Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-05-20
2008-05-20
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S486000, C424S488000, C435S455000, C527S300000
Reexamination Certificate
active
07375096
ABSTRACT:
A method of preparing a supramolecular complex containing at least one therapeutic agent and a multi-dimensional polymer network is described. A supramolecular complex prepared by a method of the invention is described. A method of treatment by administering a therapeutically effective amount of a supramolecular complex of the invention is also described. Such a supramolecular complex may be used as a delivery vehicle for various therapeutic agents.
REFERENCES:
patent: 4582865 (1986-04-01), Balazs et al.
patent: RE32268 (1986-10-01), Gordon
patent: 4727064 (1988-02-01), Pitha
patent: 4774329 (1988-09-01), Friedman
patent: 4818542 (1989-04-01), DeLuca et al.
patent: 5276088 (1994-01-01), Yoshinaga
patent: 5608015 (1997-03-01), Yoshinaga
patent: 5652347 (1997-07-01), Pouyani et al.
patent: 5656611 (1997-08-01), Kabanov et al.
patent: 5691316 (1997-11-01), Agrawal et al.
patent: 5693768 (1997-12-01), Bachmann et al.
patent: 5700848 (1997-12-01), Soon-Shiong et al.
patent: 5855900 (1999-01-01), Nobuhiko
patent: 5880154 (1999-03-01), Boukrinskaia et al.
patent: 6048736 (2000-04-01), Kosak
patent: 6132734 (2000-10-01), Thomas et al.
patent: 6207195 (2001-03-01), Walsh et al.
patent: 6353055 (2002-03-01), Kabanov et al.
patent: 6420176 (2002-07-01), Lisziewicz et al.
patent: 6509323 (2003-01-01), Davis et al.
patent: 6737447 (2004-05-01), Smith et al.
patent: 2001/0034333 (2001-10-01), Kosak
patent: 2001/0044412 (2001-11-01), Wolff et al.
patent: 0 730 869 (1996-09-01), None
patent: 2 665 169 (1992-01-01), None
patent: 1 390 479 (1975-04-01), None
patent: 2197720 (1988-05-01), None
patent: 94/02518 (1994-02-01), None
patent: WO 96/09073 (1996-03-01), None
patent: 00/01734 (2000-01-01), None
patent: WO 00/33885 (2000-06-01), None
patent: WO 00/40962 (2000-07-01), None
patent: WO 00/75162 (2000-12-01), None
patent: WO 00/75164 (2000-12-01), None
patent: WO 01/37665 (2001-05-01), None
patent: WO 02/057424 (2002-07-01), None
Pierce 1989 Handbook and General Catalog,Rockford, Illinois, 1989, only pp. 288-293 supplied.
Tabushi et al., “Artificial Receptor Recognizing Hydrophobic Carbonyl Compounds,”J. Organic Chemistry,51(10), 1918-1921 (Mar. 16, 1986).
U.S. Appl. No. 09/067,921, filed Apr. 29, 1998, Kosar et al.
Alyaudrin et al., “PEG-cyclodextrin for Tranport of Neurotropic Drug to Brain,” Russian Patent No. 2 094 059 C1, Oct. 27, 1997; See alsoIzobreteniya,1997(30), 167;Chemical Abstracts,129(13), p. 1016, Abstract No. 166200x (Sep. 29, 1998); see also HCAPlus Abstract, 1998, citation 520345; only abstract and first page of HCAPlus citation supplied.
Alexakis, T. et al. “Microencapsulation of DNA within Alginate . . . ” Appl. Biochem. Biotechnol. (1995) vol. 50, pp. 93-106.
Pulfer, S. et al. “Incorporation of nitric oxide-releasing crosslinked polyethyleneimine . . . ” J. Biomed. Mat. Res. (1997) vol. 37, No. 2, pp. 182-189.
Tanaka, R. et al “High molecular weight poly(ethylenimine) . . . ” Macromolecules (1983) vol. 16, No. 6, pp. 849-853.
Ferrari, S. et al “ExGen 500 is an efficient vector for gene delivery . . . ” Gene Therapy (1997) vol. 4, pp. 1100-1106.
Trubetskoy, Vladimir S. et al., “Self-Assembly of DNA-Polymer Complexes Using Template Polymerization”,Nucleic Acids Research,26, No. 18, pp. 4178-4185 (1998).
Zanta, Maria-Antoniette et al., “In VitroGene Delivery to Hepatocytes with Galactosylated Polyethylenimine”,Bioconjugate Chem.,8, pp. 839-844 (1997).
Husain, Noni et al., “Complexation of Doxorubicin with β- and γ-Cyclodextrins”,Applied Spectroscopy,46, No. 4, pp. 652-658 (1992).
Tabushi, Iwao et al., “Specification Bifunctionalization on Cyclodextrin”,Tetrahedron Letters,No. 18, pp. 1527-1530 (1977).
Tabushi, Iwao et al., “Bis(histamino)cyclodextrin-Zn-Imidazole Complex as an Artificial Carbonic Anhydrase”,J. Am. Chem. Soc.,106, pp. 4580-4584 (1984).
Tabushi, Iwao et al., “Characterization of Regiospecific A,C- and A,D-Disulfonate Capping of β-Cyclodextrin. Capping as an Efficient Production Technique”,J. Am. Chem. Soc.,106, pp. 5267-5270 (1984).
Lowry, Oliver H. et al., “Protein Measurement with the Folin Phenol Reagant”,The Journal of Biological Chemistry,193, pp. 265-275 (1951).
Mungall, William S. et al. “Use of the Azido Group in the Synthesis of 5′ Terminal Aminodeoxythymidine Oligonucleotides”,J. Org. Chem,40, No. 11, pp. 1659-1162 (1975).
Hisamatsu, Makato et al., “Study on Specific Modification of Glucosyl Cyclodextrins”,Starch/Stärke,44, No. 4, pp. 188-191 (1992).
Boussif, Otmane et al., “A Versatile Vector for Gene and Oligonucleotide Transfer Into Cells in Culture and In Vivo: Polyethylenimine”,Proc. Natl. Acad. Sci, USA,92, pp. 7297-7301 (Aug. 1995).
Fieser, Mary et al.,Reagents for Organic Synthesis,3, pp. 265-266, Wiley, New York, 1967.
Cserháti, Tibor, “Charge-Transfer Chromatographic Study of the Complex Formation of Some Anticancer Drugs with γ-Cyclodextrin”,Analytical Biochemistry,225, pp. 328-332 (1995).
Melton, L.D. et al., “Synthesis of Monosubstituted Cyclohexaamyloses”,Carbohydrate Research,18, No. 1, pp. 29-37 (May 1971).
Fujita Kahee et al., “Guest-Induced Conformational Change of β-Cyclodextrin Capped With an Environmentally Sensitive Chromophore”,Bioorganic Chemistry,11, pp. 72-84 (1982).
Fujita, Kahee et al., “Selective Recognition of Alkanoates by a β-Cyclodextrin Flexibly Capped With a Chromophore”,Bioorganic Chemistry,11, pp. 108-114 (1982).
Hector Gonzalez, et al., “New Class of Polymers for the Delivery of Macromolecular Therapeutics,”Bioconjugate Chem.,10, 1068-1074 (1999).
Gonzalez, et al., “New Class of Polymers for the Delivery of Macromolecular Therapeutics,”Bioconjugate Chem.,vol. 10, No. 6, pp. 1068-1074 (1999), (WEB Publ. on Sep. 24, 1999).
Hwang et al., “Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery,”Bioconjugate Chem.,vol. 12, No. 2, pp. 280-290 (2001), (WEB Publ. on Feb. 16, 2001).
Ooya, et al., “Synthesis and Characterization of an Oligopeptide-terminated Polyrotaxane as a Drug Carrier,”Polym. Adv. Technol.,vol. 11, pp. 642-651 (2000).
Pun, et al., “Development of a Nonviral Gene Delivery Vehicle for Systemic Application,”Bioconjugate Chem.,vol. 13, pp. 630-639, (2002), (WEB Publ. on Apr. 20, 2002.
“The Merck Index 11th Edition”Merck Research Laboratories,Whitehouse Station NJ XP002207314 p. 24, right-hand column, line 2-24 (1989).
“The Merck Index 11th Edition”Merck Research Laboratories,Whitehouse Station NJ XP002207313, p. 60, right-hand column, line 27—p. 61, left-hand column, line 8 (1989).
Smith, D., et al., “Nitric Oxide-Releasing Polymers Containing the [N(O)NO] Group”, J. Med. Chem. 1996, 39, 1148-1156.
Davis Mark E.
Gonzalez Hector
Hwang Suzie (Sue Jean)
California Institute of Technology
Maier Leigh C.
Ropes & Gray LLP
LandOfFree
Method of preparing a supramolecular complex containing a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing a supramolecular complex containing a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing a supramolecular complex containing a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2784143